View in EDS

Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti–PD-1 therapy.

Saved in:
Bibliographic Details
Title: Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti–PD-1 therapy.
Authors: Hepner, Adriana1,2 (AUTHOR), Atkinson, Victoria G.3 (AUTHOR), Larkin, James4 (AUTHOR), Burrell, Rebecca A.4 (AUTHOR), Carlino, Matteo S.1,5 (AUTHOR), Johnson, Douglas B.6 (AUTHOR), Zimmer, Lisa7 (AUTHOR), Tsai, Katy K.8 (AUTHOR), Klein, Oliver9 (AUTHOR), Lo, Serigne N.1 (AUTHOR), Haydon, Andrew10,11 (AUTHOR), Bhave, Prachi11 (AUTHOR), Lyle, Megan12 (AUTHOR), Pallan, Lalit1 (AUTHOR), Pires da Silva, Ines1 (AUTHOR), Gerard, Camille13 (AUTHOR), Michielin, Olivier13 (AUTHOR), Long, Georgina V.1,14,15 (AUTHOR), Menzies, Alexander M.1,14,15 (AUTHOR) alexander.menzies@sydney.edu.au
Source: European Journal of Cancer. Aug2021, Vol. 153, p213-222. 10p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2021.04.021